Nuclear functions and trafficking of receptor tyrosine Kinases

Vesicle Trafficking in Cancer

Volumn , Issue , 2013, Pages 159-176

  Wang, Ying Nai ^a,b   Hsu, Jennifer L ^a,b   Hung, Mien Chie ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949175281     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-6528-7_8     Document Type: Chapter

References (130)

1. Avraham R, Yarden Y (2011) Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 12(2):104-117
2. Citri A, Yarden Y (2006) EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7(7):505-516
3. Lo HW, Hsu SC, Hung MC (2006) EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 95(3):211-218
4. Huang PH, Xu AM, White FM (2009) Oncogenic EGFR signaling networks in glioma. Sci Signal 2(87):re6
5. Irmer D, Funk JO, Blaukat A (2007) EGFR kinase domain mutations-functional impact and relevance for lung cancer therapy. Oncogene 26(39):5693-5701
6. Gazdar AF (2009) Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene 28(suppl 1): S24-S31
7. Hynes NE, MacDonald G (2009) ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 21(2):177-184
8. Linardou H, Dahabreh IJ, Bafaloukos D, Kosmidis P, Murray S (2009) Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC. Nat Rev Clin Oncol 6(6):352-366
9. Jones FE (2008) HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer. J Mammary Gland Biol Neoplasia 13(2):247-258
10. Muraoka-Cook RS, Feng SM, Strunk KE, Earp HS III (2008) ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. J Mammary Gland Biol Neoplasia 13(2):235-246
11. Bitler BG, Goverdhan A, Schroeder JA (2010) MUC1 regulates nuclear localization and function of the epidermal growth factor receptor. J Cell Sci 123(pt 10):1716-1723
12. Merlin J, Stechly L, de Beauce S, Monte D, Leteurtre E, van Seuningen I et al (2011) Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. Oncogene 30(22):2514-2525
13. De Angelis Campos AC, Rodrigues MA, de Andrade C, de Goes AM, Nathanson MH, Gomes DA (2011) Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway. Biochem Biophys Res Commun 412(2):341-346
14. Jaganathan S, Yue P, Paladino DC, Bogdanovic J, Huo Q, Turkson J (2011) A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells. PLoS One 6(5):e19605
15. Liccardi G, Hartley JA, Hochhauser D (2011) EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res 71(3):1103-1114
16. Piccione EC, Lieu TJ, Gentile CF, Williams TR, Connolly AJ, Godwin AK et al (2012) A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors. Oncogene 31(24):2953-2967
17. Huang WC, Chen YJ, Li LY, Wei YL, Hsu SC, Tsai SL et al (2011) Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancerresistant protein expression in gefitinib-resistant cells. J Biol Chem 286(23):20558-20568
18. Cornelissen B, Darbar S, Hernandez R, Kersemans V, Tullis I, Barber PR et al (2011) ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy. J Nucl Med 52(5):776-783
19. Wang SC, Nakajima Y, Yu YL, Xia W, Chen CT, Yang CC et al (2006) Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 8(12):1359-1368
20. Ni CY, Murphy MP, Golde TE, Carpenter G (2001) Gamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294(5549):2179-2181
21. Wanner G, Mayer C, Kehlbach R, Rodemann HP, Dittmann K (2008) Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation. Radiother Oncol 86(3):383-390
22. Das AK, Chen BP, Story MD, Sato M, Minna JD, Chen DJ et al (2007) Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFRmediated radioprotection in non-small cell lung carcinoma. Cancer Res 67(11):5267-5274
23. Kim J, Jahng WJ, Di Vizio D, Lee JS, Jhaveri R, Rubin MA et al (2007) The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res 67(19):9229-9237
24. Offterdinger M, Schofer C, Weipoltshammer K, Grunt TW (2002) c-erbB-3: A nuclear protein in mammary epithelial cells. J Cell Biol 157(6):929-939
25. Massie C, Mills IG (2006) The developing role of receptors and adaptors. Nat Rev Cancer 6(5):403-409
26. de la Iglesia N, Konopka G, Puram SV, Chan JA, Bachoo RM, You MJ et al (2008) Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 22(4):449-462
27. Mosesson Y, Mills GB, Yarden Y (2008) Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8(11):835-850
28. Li C, Iida M, Dunn EF, Wheeler DL (2010) Dasatinib blocks cetuximab-and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma. Radiother Oncol 97(2):330-337
29. Li LY, Chen H, Hsieh YH, Wang YN, Chu HJ, Chen YH et al (2011) Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes. Cancer Res 71(12):4269-4279
30. Lo HW, Cao X, Zhu H, Ali-Osman F (2010) Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res 8(2):232-245
31. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Kehlbach R, Rodemann HP (2010) Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654. FEBS Lett 584(18):3878-3884
32. Liao HJ, Carpenter G (2007) Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol Biol Cell 18(3):1064-1072
33. Li CF, Fang FM, Wang JM, Tzeng CC, Tai HC, Wei YC et al (2012) EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact. Ann Surg Oncol 19(2):443-454
34. Dekanic A, Dobrila Dintinjan R, Budisavljevic I, Pecanic S, Zuvic Butorac M, Jonjic N (2011) Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification. Diagn Pathol 6:108
35. Nowsheen S, Bonner JA, Yang ES (2011) The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy. Radiother Oncol 99(3):331-338
36. Wang SC, Hung MC (2009) Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors. Clin Cancer Res 15(21):6484-6489
37. Wang YN, Wang H, Yamaguchi H, Lee HJ, Lee HH, Hung MC (2010) COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport. Biochem Biophys Res Commun 399(4):498-504
38. Wang YN, Yamaguchi H, Huo L, Du Y, Lee HJ, Lee HH et al (2010) The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus. J Biol Chem 285(49):38720-38729
39. Marti U, Burwen SJ, Wells A, Barker ME, Huling S, Feren AM et al (1991) Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology (Baltimore, MD) 13(1):15-20
40. Marti U, Hug M (1995) Acinar and cellular distribution and mRNA expression of the epidermal growth factor receptor are changed during liver regeneration. J Hepatol 23(3):318-327
41. Marti U, Ruchti C, Kampf J, Thomas GA, Williams ED, Peter HJ et al (2001) Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid 11(2):137-145
42. Marti U, Wells A (2000) The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR. Mol Cell Biol Res Commun 3(1):8-14
43. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY et al (2001) Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3(9):802-808
44. Dittmann K, Mayer C, Rodemann HP (2010) Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function. Strahlenther Onkol 186(1):1-6
45. Wang YN, Yamaguchi H, Hsu JM, Hung MC (2010) Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene 29(28):3997-4006
46. Carpenter G, Liao HJ (2009) Trafficking of receptor tyrosine kinases to the nucleus. Exp Cell Res 315(9):1556-1566
47. Brand TM, Iida M, Li C, Wheeler DL (2011) The nuclear epidermal growth factor receptor signaling network and its role in cancer. Discov Med 12(66):419-432
48. Lo HW (2010) Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications. Discov Med 10(50):44-51
49. Xu Y, Shao Y, Zhou J, Voorhees JJ, Fisher GJ (2009) Ultraviolet irradiation-induces epidermal growth factor receptor (EGFR) nuclear translocation in human keratinocytes. J Cell Biochem 107(5):873-880
50. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L et al (2005) Radiationinduced epidermal growth factor receptor nuclear import is linked to activation of DNAdependent protein kinase. J Biol Chem 280(35):31182-31189
51. Liao HJ, Carpenter G (2009) Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor. Cancer Res 69(15):6179-6183
52. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Kehlbach R, Rodemann HP (2011) Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access. Radiother Oncol 99(3):317-322
53. Xia W, Wei Y, Du Y, Liu J, Chang B, Yu YL et al (2009) Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer. Mol Carcinog 48(7):610-617
54. Hadzisejdic I, Mustac E, Jonjic N, Petkovic M, Grahovac B (2010) Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis. Mod Pathol 23(3): 392-403
55. Hoshino M, Fukui H, Ono Y, Sekikawa A, Ichikawa K, Tomita S et al (2007) Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma. Pathobiology 74(1):15-21
56. Lo HW, Xia W, Wei Y, Ali-Seyed M, Huang SF, Hung MC (2005) Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 65(1):338-348
57. Psyrri A, Egleston B, Weinberger P, Yu Z, Kowalski D, Sasaki C et al (2008) Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray. Cancer Epidemiol Biomarkers Prev 17(6):1486-1492
58. Psyrri A, Yu Z, Weinberger PM, Sasaki C, Haffty B, Camp R et al (2005) Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res 11(16):5856-5862
59. Dittmann KH, Mayer C, Ohneseit PA, Raju U, Andratschke NH, Milas L et al (2008) Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: A COX-2 independent mechanism. Int J Radiat Oncol Biol Phys 70(1):203-212
60. Hsu SC, Miller SA, Wang Y, Hung MC (2009) Nuclear EGFR is required for cisplatin resistance and DNA repair. Am J Transl Res 1(3):249-258
61. Li C, Iida M, Dunn EF, Ghia AJ, Wheeler DL (2009) Nuclear EGFR contributes to acquired resistance to cetuximab. Oncogene 28(43):3801-3813
62. Kim HP, Yoon YK, Kim JW, Han SW, Hur HS, Park J et al (2009) Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2. PLoS One 4(6):e5933
63. Chen YJ, Huang WC, Wei YL, Hsu SC, Yuan P, Lin HY et al (2011) Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells. PLoS One 6(6):e21428
64. Edwards J, Traynor P, Munro AF, Pirret CF, Dunne B, Bartlett JM (2006) The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer. Clin Cancer Res 12(1): 123-130
65. Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I et al (1993) Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res 53(21):5251-5261
66. Xie Y, Hung MC (1994) Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem Biophys Res Commun 203(3):1589-1598
67. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z et al (2004) Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6(3):251-261
68. Scaltriti M, Rojo F, Ocana A, Anido J, Guzman M, Cortes J et al (2007) Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer. J Natl Cancer Inst 99(8):628-638
69. Anido J, Scaltriti M, Bech Serra JJ, Santiago Josefat B, Todo FR, Baselga J et al (2006) Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation. EMBO J 25(13):3234-3244
70. Xia W, Liu Z, Zong R, Liu L, Zhao S, Bacus SS et al (2011) Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors. Mol Cancer Ther 10(8):1367-1374
71. Koumakpayi IH, Diallo JS, Le Page C, Lessard L, Filali-Mouhim A, Begin LR et al (2007) Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer. BJU Int 100(2):303-309
72. Koumakpayi IH, Diallo JS, Le Page C, Lessard L, Gleave M, Begin LR et al (2006) Expression and nuclear localization of ErbB3 in prostate cancer. Clin Cancer Res 12(9):2730-2737
73. Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R et al (2007): Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res 1139:95-109
74. Bueter W, Dammann O, Zscheppang K, Korenbaum E, Dammann CE (2006) ErbB receptors in fetal endothelium-A potential linkage point for inflammation-associated neonatal disorders. Cytokine 36(5-6):267-275
75. Sardi SP, Murtie J, Koirala S, Patten BA, Corfas G (2006) Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127(1):185-197
76. Junttila TT, Sundvall M, Lundin M, Lundin J, Tanner M, Harkonen P et al (2005) Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res 65(4):1384-1393
77. Naresh A, Thor AD, Edgerton SM, Torkko KC, Kumar R, Jones FE (2008) The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis. Cancer Res 68(15):6387-6395
78. Arasada RR, Carpenter G (2005) Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment. J Biol Chem 280(35):30783-30787
79. Linggi B, Carpenter G (2006) ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression. J Biol Chem 281(35):25373-25380
80. Lo HW, Hung MC (2006) Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer 94(2):184-188
81. Tseng HC, Lyu PC, Lin WC (2010) Nuclear localization of orphan receptor protein kinase (Ror1) is mediated through the juxtamembrane domain. BMC Cell Biol 11:48
82. Fiorillo AA, Medler TR, Feeney YB, Liu Y, Tommerdahl KL, Clevenger CV (2011) HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription. Mol Endocrinol 25(9):1550-1564
83. Raper SE, Burwen SJ, Barker ME, Jones AL (1987) Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology 92(5 pt 1): 1243-1250
84. Schausberger E, Eferl R, Parzefall W, Chabicovsky M, Breit P, Wagner EF et al (2003) Induction of DNA synthesis in primary mouse hepatocytes is associated with nuclear protransforming growth factor alpha and erbb-1 and is independent of c-jun. Carcinogenesis 24(5):835-841
85. Adam RM, Danciu T, McLellan DL, Borer JG, Lin J, Zurakowski D et al (2003) A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma. Cancer Res 63(2):484-490
86. Clevenger CV (2003) Nuclear localization and function of polypeptide ligands and their receptors: A new paradigm for hormone specificity within the mammary gland? Breast Cancer Res 5(4):181-187
87. Kimura H (1993) Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc Natl Acad Sci U S A 90(6):2165-2169
88. Hieda M, Isokane M, Koizumi M, Higashi C, Tachibana T, Shudou M et al (2008) Membraneanchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane. J Cell Biol 180(4):763-769
89. Bao J, Wolpowitz D, Role LW, Talmage DA (2003) Back signaling by the Nrg-1 intracellular domain. J Cell Biol 161(6):1133-1141
90. Hanada N, Lo HW, Day CP, Pan Y, Nakajima Y, Hung MC (2006) Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol Carcinog 45(1):10-17
91. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia W, Wei Y et al (2005) Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7(6):575-589
92. Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, Wu ML et al (2008) Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res 36(13):4337-4351
93. Huo L, Wang YN, Xia W, Hsu SC, Lai CC, Li LY et al (2010) RNA helicase A is a DNAbinding partner for EGFR-mediated transcriptional activation in the nucleus. Proc Natl Acad Sci U S A 107(37):16125-16130
94. Huang WC, Hung MC (2009) Induction of Akt activity by chemotherapy confers acquired resistance. J Formos Med Assoc 108(3):180-194
95. Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L et al (2004) The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 167(3):469-478
96. Hu S, Xie Z, Onishi A, Yu X, Jiang L, Lin J et al (2009) Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 139(3):610-622
97. Tan M, Jing T, Lan KH, Neal CL, Li P, Lee S et al (2002) Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxolinduced apoptosis. Mol Cell 9(5):993-1004
98. Sorkin A, von Zastrow M (2009) Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10(9):609-622
99. Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857-902
100. Johannes L, Popoff V (2008) Tracing the retrograde route in protein trafficking. Cell 135(7):1175-1187
101. Spooner RA, Smith DC, Easton AJ, Roberts LM, Lord JM (2006) Retrograde transport pathways utilised by viruses and protein toxins. Virol J 3:26
102. Hsu VW, Lee SY, Yang JS (2009) The evolving understanding of COPI vesicle formation. Nat Rev Mol Cell Biol 10(5):360-364
103. Lee MC, Miller EA, Goldberg J, Orci L, Schekman R (2004) Bi-directional protein transport between the ER and Golgi. Annu Rev Cell Dev Biol 20:87-123
104. Cai H, Reinisch K, Ferro-Novick S (2007) Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle. Dev Cell 12(5):671-682
105. Yang JS, Valente C, Polishchuk RS, Turacchio G, Layre E, Moody DB et al (2011) COPI acts in both vesicular and tubular transport. Nat Cell Biol 13(8):996-1003
106. Boerner JL, Demory ML, Silva C, Parsons SJ (2004) Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol 24(16):7059-7071
107. Demory ML, Boerner JL, Davidson R, Faust W, Miyake T, Lee I et al (2009) Epidermal growth factor receptor translocation to the mitochondria: regulation and effect. J Biol Chem 284(52):36592-36604
108. Cao X, Zhu H, Ali-Osman F, Lo HW (2011) EGFR and EGFRvIII undergo stress-and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFRdriven antagonism of apoptosis. Mol Cancer 10:26
109. Dreier A, Barth S, Goswami A, Weis J (2012) Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: involvement of mitochondria in tumor drug resistance? Tumour Biol 33(1):85-94
110. Hsu SC, Hung MC (2007) Characterization of a novel tripartite nuclear localization sequence in the EGFR family. J Biol Chem 282(14):10432-10440
111. Giri DK, Ali-Seyed M, Li LY, Lee DF, Ling P, Bartholomeusz G et al (2005) Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol 25(24):11005-11018
112. Lo HW, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu SC, Hung MC (2006) Nuclearcytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J Cell Biochem 98(6):1570-1583
113. Wang ZH, Tian XX, Cheng Y, Yam GH, Ng HK, Ding MX et al (1998) Association of EGFR gene fragments with nuclear matrices in glioblastoma cell lines. Anticancer Res 18(6A):4329-4332
114. Klein C, Gensburger C, Freyermuth S, Nair BC, Labourdette G, Malviya AN (2004) A 120 kDa nuclear phospholipase Cgamma1 protein fragment is stimulated in vivo by EGF signal phosphorylating nuclear membrane EGFR. Biochemistry 43(50):15873-15883
115. Sanderson MP, Keller S, Alonso A, Riedle S, Dempsey PJ, Altevogt P (2008) Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloproteasedependent ectodomain shedding and exosome secretion. J Cell Biochem 103(6):1783-1797
116. Adamczyk KA, Klein-Scory S, Tehrani MM, Warnken U, Schmiegel W, Schnolzer M et al (2011) Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells. Life Sci 89(9-10):304-312
117. Perez-Torres M, Valle BL, Maihle NJ, Negron-Vega L, Nieves-Alicea R, Cora EM (2008) Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells. Exp Cell Res 314(16):2907-2918
118. Arscott WT, Camphausen KA (2011) EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer. Biomark Med 5(6):821
119. Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9(8):581-593
120. Zhang HG, Grizzle WE (2011) Exosomes and cancer: A newly described pathway of immune suppression. Clin Cancer Res 17(5):959-964
121. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73(10):1907-1920
122. Simons M, Raposo G (2009) Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 21(4):575-581
123. Schorey JS, Bhatnagar S (2008) Exosome function: from tumor immunology to pathogen biology. Traffic 9(6):871-881
124. Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA et al (2009) Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 23(5):1541-1557
125. Zhen Y, Caprioli RM, Staros JV (2003) Characterization of glycosylation sites of the epidermal growth factor receptor. Biochemistry 42(18):5478-5492
126. Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ et al (2011) Amphiregulin exosomes increase cancer cell invasion. Curr Biol 21(9):779-786
127. Progida C, Cogli L, Piro F, De Luca A, Bakke O, Bucci C (2010) Rab7b controls trafficking from endosomes to the TGN. J Cell Sci 123(pt 9):1480-1491
128. Dunham-Ems SM, Pudavar HE, Myers JM, Maher PA, Prasad PN, Stachowiak MK (2006) Factors controllingfibroblast growth factor receptor-1's cytoplasmic trafficking and its regulation as revealed by FRAP analysis. Mol Biol Cell 17(5):2223-2235
129. Stachowiak MK, Maher PA, Stachowiak EK (2007) Integrative nuclear signaling in cell development-A role for FGF receptor-1. DNA Cell Biol 26(12):811-826
130. Reilly JF, Maher PA (2001) Importin beta-mediated nuclear import offibroblast growth factor receptor: role in cell proliferation. J Cell Biol 152(6):1307-1312